Dir
Louise C. Forlenza is an independent director of Innodata Inc. (NASDAQ: INOD), where she has served on the board since October 2002 and chairs the audit committee while also serving on key governance and compensation committees.[[1]](https://investor.innodata.com/governance/board-of-directors/person-details/default.aspx?ItemId=ed8f2d4a-2958-490c-b842-cbc74641b5b9)[[2]](https://e.givesmart.com/events/KKY/c/:LvtXRVXei1s/)[[6]](https://investor.innodata.com/governance/board-of-directors/default.aspx) A New York State–licensed Certified Public Accountant, she is the founder and principal of LC Forlenza Advisory Services, established in 1987, through which she has provided strategic insight in global accounting and reporting, forensic accounting, auditing, foreign tax issues, turnarounds, and litigation support to more than 250 domestic and international clients across sectors including technology, real estate, entertainment, transportation, and health and wellness.[[1]](https://investor.innodata.com/governance/board-of-directors/person-details/default.aspx?ItemId=ed8f2d4a-2958-490c-b842-cbc74641b5b9)[[2]](https://e.givesmart.com/events/KKY/c/:LvtXRVXei1s/)[[3]](https://theorg.com/org/ned-biosystems/org-chart/louise-forlenza) She has also served on the advisory committee and board of NED Biosystems, a clinical-stage biotech firm, and previously chaired the audit committee and served as treasurer of The Acting Company.[[2]](https://e.givesmart.com/events/KKY/c/:LvtXRVXei1s/)[[3]](https://theorg.com/org/ned-biosystems/org-chart/louise-forlenza)
Earlier in her career, Forlenza held senior operating and finance roles, including Chief Financial Officer and Chief Operating Officer of Intercontinental Exchange Partners, an international foreign exchange company, and Chief Financial Officer of Bierbaum-Martin, a foreign exchange firm.[[1]](https://investor.innodata.com/governance/board-of-directors/person-details/default.aspx?ItemId=ed8f2d4a-2958-490c-b842-cbc74641b5b9) She also served as CFO/COO of Selby Transportation Corporation, guiding its expansion and eventual sale to private equity.[[2]](https://e.givesmart.com/events/KKY/c/:LvtXRVXei1s/) Forlenza earned a B.B.A. in Accounting from Iona College (where she was the first and only female accounting major in her graduating class), a Certificate in Forensic Accounting from New York University, and has completed executive programs in board governance, audit, and executive compensation at Harvard Business School and additional executive training at The Wharton School.[[1]](https://investor.innodata.com/governance/board-of-directors/person-details/default.aspx?ItemId=ed8f2d4a-2958-490c-b842-cbc74641b5b9)[[2]](https://e.givesmart.com/events/KKY/c/:LvtXRVXei1s/)[[3]](https://theorg.com/org/ned-biosystems/org-chart/louise-forlenza) Her extensive boardroom and audit committee experience underpin her role as a financial expert and corporate governance leader at Innodata.[[1]](https://investor.innodata.com/governance/board-of-directors/person-details/default.aspx?ItemId=ed8f2d4a-2958-490c-b842-cbc74641b5b9)[[2]](https://e.givesmart.com/events/KKY/c/:LvtXRVXei1s/)[[3]](https://theorg.com/org/ned-biosystems/org-chart/louise-forlenza)[[7]](https://www.sec.gov/Archives/edgar/data/903651/000110465921053670/tm2113214d1_def14a.htm)
View full insider profile →
Discussion